Head of Iran’s National Institute of Genetic Engineering and Biotechnology said that the Iranian anti-cancer vaccine will be unveiled in the summer of 2025 which is developed by companies based at the research institute.

According to The Iran Project, Javad Mohammadi stated that this vaccine will be able to cover all types of cancers and it will be unveiled in the summer of 2025.

Mohammadi mentioned that knowledge-based companies based at the Genetic Research Institute will unveil two new products. 

Referring to the success of knowledge-based companies in localizing this technology, he stated that these companies will able to meet 70 percent of the country's needs.

It is expected that these companies will provide up to 100 percent of the country's needs, he said, adding that this great achievement will greatly help reduce the country's dependence on imports and improve the treatment conditions of patients.

He stressed that Iran's dependence on these drugs from abroad will be completely cut off.